Here’s a history of the drug tenofovir, which became one of the world’s most-prescribed drugs for HIV, bringing in $11 billion in annual sales for biotech firm Gilead Sciences. 1986 A Czech Republic scientist files for a U.S. patent on tenofovir. 1997 Scientists from Gilead and UC San Francisco...